BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38001065)

  • 21. METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.
    Liu B; Cao J; Wu B; Hao K; Wang X; Chen X; Shen Z
    Cell Commun Signal; 2023 May; 21(1):121. PubMed ID: 37231451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling.
    Liu X; He H; Zhang F; Hu X; Bi F; Li K; Yu H; Zhao Y; Teng X; Li J; Wang L; Zhang Y; Wu Q
    Cell Death Dis; 2022 May; 13(5):483. PubMed ID: 35595748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUMOylation of methyltransferase-like 3 facilitates colorectal cancer progression by promoting circ_0000677 in an m
    Liu Q; Huang Q; Liu H; He FJ; Liu JH; Zhou YY; Zeng MT; Pei Q; Zhu H
    J Gastroenterol Hepatol; 2022 Apr; 37(4):700-713. PubMed ID: 35030640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extract of
    Huang X; Chen Y; Zhang X; Li F; Ye H
    Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
    [No Abstract]   [Full Text] [Related]  

  • 25. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
    Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
    Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.
    Ding Z; Kloss JM; Tuncali S; Tran NL; Loftus JC
    Neoplasia; 2020 Sep; 22(9):352-364. PubMed ID: 32629176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
    Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
    Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling.
    Zhang X; Yang J; Bian Z; Shi D; Cao Z
    Biomed Pharmacother; 2019 May; 113():108713. PubMed ID: 30849642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.
    Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R
    Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
    Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
    Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
    Li S; Jiang F; Chen F; Deng Y; Pan X
    J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via JAK1/STAT3 Signaling Pathway.
    Luo N
    Comput Math Methods Med; 2022; 2022():1447207. PubMed ID: 36213586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LIF-JAK1-STAT3 signaling delays contact inhibition of human corneal endothelial cells.
    Liu X; Tseng SC; Zhang MC; Chen SY; Tighe S; Lu WJ; Zhu YT
    Cell Cycle; 2015; 14(8):1197-206. PubMed ID: 25695744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.
    Zhu W; Si Y; Xu J; Lin Y; Wang JZ; Cao M; Sun S; Ding Q; Zhu L; Wei JF
    J Cell Mol Med; 2020 Mar; 24(6):3521-3533. PubMed ID: 32039568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.